A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Rallybio Corp stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 22,119 shares of RLYB stock, worth $21,013. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,119
Previous 45,531 51.42%
Holding current value
$21,013
Previous $61 Million 57.58%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.09 - $1.45 $25,519 - $33,947
-23,412 Reduced 51.42%
22,119 $25.9 Million
Q2 2024

Aug 14, 2024

BUY
$1.34 - $2.98 $61,011 - $135,682
45,531 New
45,531 $61 Million

Others Institutions Holding RLYB

About Rallybio Corp


  • Ticker RLYB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,132,000
  • Market Cap $30.5M
  • Description
  • Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...
More about RLYB
Track This Portfolio

Track Point72 Asia (Singapore) Pte. Ltd. Portfolio

Follow Point72 Asia (Singapore) Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asia (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asia (Singapore) Pte. Ltd. with notifications on news.